This monitor provides an overview of the most important results of the cervical cancer screening for the period between November 2023 and December 2024.

The results of the second monitor are:

• The screening process on each island has been optimally tailored to that island’s unique local situation. This approach was maintained.
• The available information materials enable people to make an informed decision.
• Everyone who performs the cervical swab test has received training or refresher courses.
• All analyses are performed by a single accredited laboratory on Curaçao. This laboratory performs the human papillomavirus test (HPV typing) as well as cytology screening for cancer cells.
• The RIVM screening organization is responsible for the entire screening process. Various tasks, such as public information and sampling, have been delegated to local partners.
• Data from Saba and Sint Eustatius have been combined to ensure that data from this monitor cannot be traced to individuals.
• The screening process follows the guidelines applicable in the European Netherlands as closely as possible.